Firas El Chaer, MD, Publishes on Prevention and Treatment of COVID-19 in Patients with Hematologic Malignancies and Recipients of Cellular Therapies

August 19, 2022 by jta6n@virginia.edu

Firas El Chaer, MDFiras El Chaer, MD, an assistant professor in the Department of Medicine, Division of Hematology and Oncology, published an article in the American Society of Hematology’s Blood on August 18, 2022. Using 3 illustrative cases, El Chaer and colleagues discuss the options for the prevention and therapy of COVID-19 infection in patients with hematologic malignancies and recipients of cellular therapies. The authors provide useful, practical recommendations and algorithms for current treatment.

Read Dr. El Chaer’s article entitled “How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies.”

Read more about Dr. El Chaer’s clinical practice, research interests, and publications: https://uvahealth.com/findadoctor/profile/firas-el-chaer

Original Source

Filed Under: Clinical, Faculty